Leading medical technology company -
Integra LifeSciences Holdings Corporation
) gained the U.S. Food and Drug Administration (FDA) approval for
its Camino Flex Ventricular Catheter for use with magnetic
resonance imaging (MRI). The Camino Flex Ventricular Catheter is
used in conjunction with Integra's next-generation Camino
According to Integra, Camino Flex is a tunneled ventricular
catheter and is MR conditional at 1.5 and 3.0 T. The product
clearly has a clinical advantage over other tunneled ventricular
catheters as it is capable of consistently monitoring
intracranial pressure (ICP) independently in the ventricles.
The Camino Flex Ventricular Catheter, when used along with the
Camino Monitor, equips healthcare providers with a highly
advanced and innovative technology to efficiently diagnose and
treat complex and compromised neurological conditions. With the
increasing demand of MRI for patients undergoing neuromonitoring
and with approximately 800 centers in the U.S. using the Camino
platform, we believe, this FDA approval will strengthen the
foothold of Integra in the market for neurological and
The Camino Flex Ventricular Catheter falls under the company's
U.S. Neurosurgery business segment, which contributed 20.6% of
total revenues in 2013. In a bid to enhance its product offerings
under this segment, Integra acquired the DuraSeal product lines
) in Jan 2014. We believe Integra is steadily executing its
strategy of accelerated growth through its near-term objectives
like portfolio optimization and strategic corporate
The U.S. neurosurgical market is dominated by certain major
) which also have similar offerings. A peer-product worth
mentioning is Medtronic's Duet External Drainage and Monitoring
System that is MRI-safe to 3 Tesla (without laser).
Therefore, we would like to remain on the sidelines until
more visibility is obtained about the performance and future
demand for Integra's Camino Flex Ventricular Catheter.
Currently, Integra carries a Zacks Rank #3 (Hold). Covidien
is, however, a better-ranked stock in the broader medical sector
with a Zacks Rank #2 (Buy).
COVIDIEN PLC (COV): Free Stock Analysis
INTEGRA LIFESCI (IART): Free Stock Analysis
MEDTRONIC (MDT): Free Stock Analysis Report
STRYKER CORP (SYK): Free Stock Analysis
To read this article on Zacks.com click here.